Diagnostic Solutions

Blackstone and TPG to Take Hologic Private in Deal Valued at Up to $18.3 Billion

The agreement offers $76 in cash per share plus up to $3 tied to breast health revenue, with closing targeted in the first half of 2026 pending all required approvals.